CAR-M cell therapy (Carisma Therapeutics/Moderna)

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameCAR-M cell therapy (Carisma Therapeutics/Moderna)
Drug Alias NameIn vivo CAR-macrophage therapies (Carisma Therapeutics/Moderna)chimeric antigen receptor monocytes and macrophages cell therapy(Carisma Therapeutics/Moderna)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy > Chimeric antigen receptor Macrophages therapy > in vivo CAR-Macrophages therapyCell and gene therapy > Cell therapy > In vivo cell therapy > in vivo CAR-Macrophages therapyCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionCell replacementsGlypican-3 modulators
TargetsGlypican-3
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarisma Therapeutics IncModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncCarisma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A